Treatment of skin disorders using thieno[2,3-D]pyrimidinediones

Details Treatment of skin disorders using thieno[2,3-D]pyrimidinediones Treatment of skin disorders using thieno[2,3-D]pyrimidinediones

2006-01-10

2006-01-10

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S258100, C544S278000

Reexamination Certificate

active

06984644

ABSTRACT:
The invention provides pharmaceutically useful thieno[2,3-d]pyrimidinediones, processes for their production, pharmaceutical compositions containing them and methods of treatment involving their use.

REFERENCES:
patent: 0 640 606 (1995-03-01), None
patent: 98/02162 (1998-01-01), None
Serfling et al. The role of NF-AT transcription factors in T cell activation and differenctiation, Biochem. Biophys. Acta, 1498: 1-18, 2000.
Chemical Abstracts, vol. 112, pp. 722-723 (1990).
Gutschow et al, “3-Mercaptoalkylthieno[2,3-d]pyrimidin-2,4(1 H,3H)-dione: Sythese . . . ,” Arch. Pharm. (Weinheim), vol. 328, pp. 231-234 (1995).
Serfling et al; The role of NFAT transcription factors in T cell activation and differentiation, Biochim, Biophys, Acta, 1498:1-8.
Meagher, L.J., et al; “Atopic Dermitatis: Review of Immunopathogenesis and Advances in Immunosuppressive Therapy”;Australas, J. Dermatol; vol. 43, pp. 247-254 (2002).
Yu, F.C., et al; “Refractory Atopic Dermatitis Treated with Low Dose Cyclosporine”;Ann. Asthma. Immunol.; vol. 89, pp. 127-131 (2002).
Perrett, C.M., et al; “Cyclocporin in Childhood Psoriasis”;J. Dermatolog. Treat.; vol. 14; pp-113-118 (2003).
Tan, M.H., et al; “Psoriasis”;Drugs Today; vol. 34, pp. 641-647 (1998). (Abstract).
Thestrap-Pedersen, K. ; Tacrolimus Treatment of Atopic Eczema/Dermatitis;Curr. Opin. Allergy. Clin. Immunol.; vol. 3; pp. 359-362 (2003).
Gupta, A.K., et al; “Tacrolimus: A Review of its use for the Management of Dermatoses”;J. Eur. Acad. Dermtol. Venereal; vol. 16, pp. 100-114 (2002).
Wolff, K., et al; “Pimecrolimus for Treatment of Inflammatory Skin Disease”;Exper. Opin. Pharmacother; vol. 5, pp. 643-655 (2004).
Yamamoto, T., et al; “Topical Tacrolimus: An Effective Therapy for Facial Psorasis”;Eur. J. Dermatol; vol. 13, pp. 471-473 (2003).

Affiliated with

Also associated with

Rating

Treatment of skin disorders using thieno[2,3-D]pyrimidinediones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of skin disorders using thieno[2,3-D]pyrimidinediones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of skin disorders using thieno[2,3-D]pyrimidinediones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3536469